Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 4 sources · 3 days · First seen 18 days ago · Last updated 16 days ago

K-MEDI Hub medical industry partnerships

Overview

The K-MEDI Hub (Daegu-Gyeongbuk Advanced Medical Industry Foundation) has entered into several strategic partnerships to advance South Korea’s medical and biotechnology sectors.

Initially, the K-MEDI Hub signed a memorandum of understanding with the Daegu Gyeongbuk Institute of Science and Technology (DGIST) to combine basic science research with medical verification infrastructure. This partnership focuses on accelerating the development and commercialization of core technologies through joint research and the exchange of personnel.

Subsequently, the K-MEDI Hub expanded its collaborative efforts through two additional agreements. One partnership with New Cancer Cure Bio aims to support the development and production of the pancreatic cancer drug KN510713, specifically assisting with Phase 2 clinical trials. A second agreement with Kyung Hee University College of Dentistry focuses on strengthening research and development for dental medical products and biomaterials.

Entities

K-MEDI Hub · Seoul Economic Promotion Agency · New Cancer Cure Bio · Korea Polytechnic University · Kyung Hee University College of Dentistry

Timeline

16 days ago

[BUSINESS] 2 sources
K-MEDI Hub signs MOUs for cancer drug and dental device R&D
K-MEDI Hub has signed two MOUs in South Korea: one with New Cancer Cure Bio to develop pancreatic cancer treatments and another with Kyung Hee University to advance dental medical device R&D.
18 days ago

[BUSINESS] 4 sources
DGIST and K-MEDI Hub partner to advance medical industry
DGIST and K-MEDI Hub signed an MOU to collaborate on medical and biotechnology research, aiming to accelerate the commercialization of advanced medical technologies in South Korea.

Sources

bokuennews.com · m.imaeil.com · startuprecipe.co.kr · thebionews.net